Pantiora P, Furlan V, Matiadis D, Mavroidi B, Perperopoulou F, Papageorgiou A
Antioxidants (Basel). 2023; 12(1).
PMID: 36670925
PMC: 9854774.
DOI: 10.3390/antiox12010063.
Durmaz V, Kochl K, Krassnigg A, Parigger L, Hetmann M, Singh A
Sci Rep. 2022; 12(1):14534.
PMID: 36008461
PMC: 9406262.
DOI: 10.1038/s41598-022-18507-y.
Akkus E, Tayfuroglu O, Yildiz M, Kocak A
J Chem Inf Model. 2022; 62(17):4095-4106.
PMID: 35972783
PMC: 9472276.
DOI: 10.1021/acs.jcim.2c00601.
Ohlknecht C, Katz S, Kross C, Sprenger B, Engele P, Schneider R
J Chem Inf Model. 2021; 61(3):1193-1203.
PMID: 33570387
PMC: 8023567.
DOI: 10.1021/acs.jcim.0c01216.
Wan S, Potterton A, Husseini F, Wright D, Heifetz A, Malawski M
Interface Focus. 2020; 10(6):20190128.
PMID: 33178414
PMC: 7653344.
DOI: 10.1098/rsfs.2019.0128.
How Good is Jarzynski's Equality for Computer-Aided Drug Design?.
Ho K, Truong D, Li M
J Phys Chem B. 2020; 124(26):5338-5349.
PMID: 32484689
PMC: 7590978.
DOI: 10.1021/acs.jpcb.0c02009.
Experimental versus predicted affinities for ligand binding to estrogen receptor: iterative selection and rescoring of docked poses systematically improves the correlation.
Wright J, Anderson J, Shadnia H, Durst T, Katzenellenbogen J
J Comput Aided Mol Des. 2013; 27(8):707-21.
PMID: 23975271
DOI: 10.1007/s10822-013-9670-6.
Amino Acid derivatives as new zinc binding groups for the design of selective matrix metalloproteinase inhibitors.
Giustiniano M, Tortorella P, Agamennone M, Di Pizio A, Rossello A, Nuti E
J Amino Acids. 2013; 2013:178381.
PMID: 23555050
PMC: 3608355.
DOI: 10.1155/2013/178381.
Oxidative inhibition of Hsp90 disrupts the super-chaperone complex and attenuates pancreatic adenocarcinoma in vitro and in vivo.
Sarkar S, Dutta D, Samanta S, Bhattacharya K, Pal B, Li J
Int J Cancer. 2012; 132(3):695-706.
PMID: 22729780
PMC: 3910101.
DOI: 10.1002/ijc.27687.
Cellular quantitative structure-activity relationship (Cell-QSAR): conceptual dissection of receptor binding and intracellular disposition in antifilarial activities of Selwood antimycins.
Natesan S, Wang T, Lukacova V, Bartus V, Khandelwal A, Subramaniam R
J Med Chem. 2012; 55(8):3699-712.
PMID: 22468611
PMC: 3338160.
DOI: 10.1021/jm201371y.
Identification of HIV inhibitors guided by free energy perturbation calculations.
Acevedo O, Ambrose Z, Flaherty P, Aamer H, Jain P, Sambasivarao S
Curr Pharm Des. 2012; 18(9):1199-216.
PMID: 22316150
PMC: 3605731.
DOI: 10.2174/138161212799436421.
Binding affinity prediction for ligands and receptors forming tautomers and ionization species: inhibition of mitogen-activated protein kinase-activated protein kinase 2 (MK2).
Natesan S, Subramaniam R, Bergeron C, Balaz S
J Med Chem. 2012; 55(5):2035-47.
PMID: 22280316
PMC: 3315360.
DOI: 10.1021/jm201217q.
The linear interaction energy method for the prediction of protein stability changes upon mutation.
Wickstrom L, Gallicchio E, Levy R
Proteins. 2011; 80(1):111-25.
PMID: 22038697
PMC: 3240711.
DOI: 10.1002/prot.23168.
Computational perspectives into plasmepsins structure-function relationship: implications to inhibitors design.
Gil L A, Valiente P, Pascutti P, Pons T
J Trop Med. 2011; 2011:657483.
PMID: 21760810
PMC: 3134243.
DOI: 10.1155/2011/657483.
3-Hydroxypyrimidine-2,4-diones as an inhibitor scaffold of HIV integrase.
Tang J, Maddali K, Metifiot M, Sham Y, Vince R, Pommier Y
J Med Chem. 2011; 54(7):2282-92.
PMID: 21381765
PMC: 3072462.
DOI: 10.1021/jm1014378.
Absolute binding free energy calculations: on the accuracy of computational scoring of protein-ligand interactions.
Singh N, Warshel A
Proteins. 2010; 78(7):1705-23.
PMID: 20186976
PMC: 2868600.
DOI: 10.1002/prot.22687.
A comprehensive examination of the contributions to the binding entropy of protein-ligand complexes.
Singh N, Warshel A
Proteins. 2010; 78(7):1724-35.
PMID: 20186973
PMC: 3064472.
DOI: 10.1002/prot.22689.
Screening of benzamidine-based thrombin inhibitors via a linear interaction energy in continuum electrostatics model.
Nicolotti O, Giangreco I, Miscioscia T, Convertino M, Leonetti F, Pisani L
J Comput Aided Mol Des. 2010; 24(2):117-29.
PMID: 20148287
DOI: 10.1007/s10822-010-9320-1.
Discovery of a non-peptidic inhibitor of west nile virus NS3 protease by high-throughput docking.
Ekonomiuk D, Su X, Ozawa K, Bodenreider C, Pheng Lim S, Yin Z
PLoS Negl Trop Dis. 2009; 3(1):e356.
PMID: 19159012
PMC: 2613028.
DOI: 10.1371/journal.pntd.0000356.
Calculation of binding affinities of HIV-1 RT and beta-secretase inhibitors using the linear interaction energy method with explicit and continuum solvation approaches.
English N
J Mol Model. 2007; 13(10):1081-97.
PMID: 17690926
DOI: 10.1007/s00894-007-0229-0.